Profile for Genetic Technologies Ltd (GENE)

$ 2.29   -0.06 (-2.55%) Volume: 555.44k 4:00 PM EDT 13-Jul-2020
After Hours:  $ 2.31   0.02 (+0.87%) Volume: 13.04k 7:45 PM EDT 13-Jul-2020
Business Description:
Genetic Technologies Ltd is a molecular diagnostics company which offers predictive testing and assessment tools to help physicians manage women's health. It has developed BREVAGenplus, which is a is a clinically validated risk assessment test.
Address: 60-66 Hanover Street, P.O. Box 115, Fitzroy, VIC, AUS, 3065
Telephone: +61 384127000 Website:
Facsimile: +61 384127040 Email: N/A
CEO: Jerzy Muchnicki
Employees: 16 Market Cap: 27.53m
Issue Type: CS
Auditor: PricewaterhouseCoopers
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1166272
Industry: Medical Diagnostics & Research
Sub-Industry:    Diagnostics & Research
SIC: Biological Products, Except Diagnostic Substances (2836)